ApoE e2 and aging-related outcomes in 379,000 UK Biobank participants

Chia-Ling Kuo; Luke C. Pilling; Janice L. Atkins; George A. Kuchel; David Melzer

doi:10.1101/2020.02.12.20022459

Data Availability

This research conducted using the UK Biobank resource, under application 14631. UK Biobank received an approval from the UK Biobank Research Ethics Committee (REC) (REC reference 11/NW/0382). All the participants provided written informed consent to participate in the study and for their data to be used in future research.

https://www.ukbiobank.ac.uk/

Comments

medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions and read our Comment Policy before commenting. The content of a comment is not endorsed by medRxiv.

Community Reviews

medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors.

Community reviews for this article:

There are no community reviews for this paper.

Automated Evaluations

Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv.

Automated Evaluations:

There are no automated evaluations for this paper.

ApoE e2 and aging-related outcomes in 379,000 UK Biobank participants

Data Availability

Subject Area

Citation Manager Formats

ApoE e2 and aging-related outcomes in 379,000 UK Biobank participants

Data Availability

Subject Area

Follow this preprint